Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Monopar Therapeutics Inc (MNPR) just unveiled an update.
Monopar Therapeutics Inc. recently announced a significant milestone in their innovative radiopharma program, MNPR-101-Zr, by showcasing preclinical data in a poster presentation at the prestigious Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto. This development represents a promising step for the company in the field of nuclear medicine.
See more data about MNPR stock on TipRanks’ Stock Analysis page.